Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL509234 | 0.91 | PDE4D (1.00) | PDE4DPDE4A | |
| SCHEMBL17554760 | 0.88 | PDE4D (0.76) | PDE4D | |
| SCHEMBL17554759 | 0.86 | PDE4D (0.74) | PDE4D | |
| SCHEMBL508445 | 0.85 | PDE4D (0.73) | PDE4DPDE4A | |
| SCHEMBL17554737 | 0.85 | PDE4D (0.79) | PDE4D | |
| SCHEMBL510042 | 0.84 | PDE4D (0.78) | PDE4D | |
| SCHEMBL508039 | 0.84 | PDE4D (0.80) | PDE4D | |
| SCHEMBL3469982 | 0.83 | PDE4D (0.84) | PDE4D | |
| SCHEMBL509668 | 0.82 | PDE4D (1.00) | PDE4D | |
| SCHEMBL509661 | 0.82 | PDE4D (0.82) | PDE4DPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379548-B1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA AS (DK) | 2016-03-09 | — | — | EP | claimed |
| US-8952162-B2 | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases | LEO PHARMA A/S (DK) | 2015-02-10 | — | — | US | claimed |
| EP-2379548-B1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA AS (DK) | 2016-03-09 | — | — | EP | disclosed |
| US-8952162-B2 | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases | LEO PHARMA A/S (DK) | 2015-02-10 | — | — | US | disclosed |
| WO-2010069322-A1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA A/S (DK) | 2010-06-24 | — | — | WO | disclosed |